Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hematopoietic Stem Cell Transplant Associated Thrombotic Microangiopathy (HSCT-TMA)”

10 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 10 of 10 results

Not applicableLooking for participantsNCT06102694
What this trial is testing

Identification of Plasma Biomarkers for Early Diagnosis of Transplant-associated Thrombotic Microangiopathy

Who this might be right for
Thrombotic MicroangiopathiesHematopoietic Stem Cell Transplantation
Institute of Hematology & Blood Diseases Hospital, China 500
Not applicableLooking for participantsNCT07059026
What this trial is testing

Thrombotic Microangiopathy (TMA) Associated With Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) In Adult Patients

Who this might be right for
Thrombotic Microangiopathy
ITAC (Instituto de Trasplantes y Alta Complejidad) 200
Not applicableAvailableNCT02355782
What this trial is testing

OMS721 Compassionate Use in Patients With Thrombotic Microangiopathy

Who this might be right for
Thrombotic Microangiopathy
Michal Nowicki
Large-scale testing (Phase 3)Study completedNCT04543591
What this trial is testing

Ravulizumab in Thrombotic Microangiopathy After Hematopoietic Stem Cell Transplant

Who this might be right for
Thrombotic Microangiopathy
Alexion Pharmaceuticals, Inc. 148
Testing effectiveness (Phase 2)Study completedNCT05148299
What this trial is testing

Pegcetacoplan for Patients With Transplant-associated Thrombotic Microangiopathy After Hematopoietic Stem Cell Transplantation

Who this might be right for
Transplant-Associated Thrombotic Microangiopathy
Swedish Orphan Biovitrum 12
Not applicableApproved For MarketingNCT04247906
What this trial is testing

Single Patient Expanded Access Treatment Plan For The Investigational Product Narsoplimab

Who this might be right for
Hematopoietic Stem Cell Transplant Associated Thrombotic Microangiopathy (HSCT-TMA)
Omeros Corporation
Testing effectiveness (Phase 2)Study completedNCT03518203
What this trial is testing

Eculizumab to Treat Thrombotic Microangiopathy/Atypical Hemolytic Uremic Syndrome -Associated Multiple Organ Dysfunction Syndrome in Hematopoietic Stem Cell Transplant Recipients

Who this might be right for
Thrombotic MicroangiopathiesAtypical Hemolytic Uremic SyndromeMultiple Organ Dysfunction Syndrome
Children's Hospital Medical Center, Cincinnati 23
Not applicableNot Yet RecruitingNCT07381205
What this trial is testing

Assessing the Incidence of Transplant Associated Thrombotic Microangiopathy (TA-TMA) in Adult Patients Undergoing Allogeneic Stem Cell Transplant (SCT)

Who this might be right for
Transplant Associated Microangiopathy TAMTransplant Complication
Manuel Ricardo Espinoza-Gutarra 85
Not applicableWithdrawnNCT04970004
What this trial is testing

Study in Adult and Pediatric Patients With HSCT-TMA

Who this might be right for
Stem Cell Transplant ComplicationsThrombotic Microangiopathies
Alexion Pharmaceuticals, Inc.
Not applicableNot Yet RecruitingNCT07347990
What this trial is testing

Safety and Efficacy of Iptacopan in Patients With High-Risk Transplantation-Associated Thrombotic Microangiopathy

Who this might be right for
Thrombotic MicroangiopathyHematopoietic Stem Cell Transplantation (HSCT)
First Affiliated Hospital of Zhejiang University 30